Evaluation of Extraocular Muscles in the Edematous Phase of Graves Ophthalmopathy on Contrast-Enhanced Fat-Suppressed Magnetic Resonance Imaging

Journal of Computer Assisted Tomography

Volumn 28, Issue 1, 2004, Pages 80-86

  Cakirer, Sinan ^a,c   Cakirer, Derya ^b   Basak, Muzaffer ^a   Durmaz, Sevtap ^a   Altuntas, Yuksel ^a   Yigit, Ulviye ^a  

^a SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Ophthalmology Section   (Turkey)

^c NONE   (Turkey)

Author keywords

Contrast enhancement; Extraocular muscles; Graves ophthalmopathy; Magnetic resonance (MR); Orbita

Indexed keywords

CHEMICAL SHIFT; GRADING; MAGNETISM; MICROCIRCULATION; MUSCLE;

CONTRAST ENHANCEMENT; CONTRAST-ENHANCED; EXTRAOCULAR MUSCLES; FAT SUPPRESSION; GRAVE OPHTHALMOPATHY; INTRAVENOUS ADMINISTRATION; MAGNETIC RESONANCE; ORBITA; T1-WEIGHTED; VASCULAR SUPPLY;

MAGNETIC RESONANCE IMAGING;

CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; EDEMA; ENDOCRINE OPHTHALMOPATHY; EXTRAOCULAR MUSCLE; EYE DISEASE; FEMALE; GRAVES DISEASE; HUMAN; INFLAMMATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBIT DISEASE; PRIORITY JOURNAL; TEMPORALIS MUSCLE;

EID: 0346725963     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004728-200401000-00013     Document Type: Article

References (31)

1. Weber AL, Dallow RL, Sabates NR. Graves' disease of the orbit. Neuroimaging Clin N Am. 1996;6:61-72.
2. Kahaly GJ. Imaging in thyroid-associated orbitopathy. EurJEndocrinol. 2001;145:117-128.
3. Scott IU, Siatkowski MR. Thyroid eye disease. Semin Ophthalmol. 1999; 14:52-61.
4. Kendall-Taylor P, Perros P. Clinical presentation of thyroid-associated orbitopathy. Thyroid. 1998;8:423-425.
5. McKinnon SG, Gentry LR. Systemic diseases involving the orbit. Semin Ultrasound CT MR. 1998;19:292-308.
6. Bahn RS, Heufelder AE. Pathogenesis of Graves' ophthalmopathy. New Engl J Med. 1993;329:1468-1475.
7. Oguz V, Yolar M, Yetik H, et al. Value of MRI in the treatment of Grave's disease orbital myopathy. J Fr Ophtalmol. 2001;24:842-846.
8. Nagy EV, Toth J, Kaldi I, et al. Graves' ophthalmopathy: eye muscle involvement in patients with diplopia. Eur J Endocrinol. 2000;142: 591-597.
9. Amano Y, Amano M, Kumazaki T. Normal contrast enhancement of extraocular muscles: fat-suppressed MR findings. AJNR Am J Neuroradiol. 1997;18:161-164.
10. Taoka T, Iwasaki S, Uchida H, et al. Enhancement pattern of normal extraocular muscles in dynamic contrast-enhanced MR imaging with fat suppression. Acta Radiol. 2000;41:211-216.
11. Ott M, Breiter N, Albrecht CF, et al. Can contrast enhanced MRI predict the response of Graves' ophthalmopathy to orbital radiotherapy? Br J Radiol. 2002;75:514-517.
12. Pauleit D, Schuller H, Textor J, et al. MR relaxation time measurements with and without selective fat suppression (SPIR) in endocrine orbitopathy. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr. 1997;167: 557-564.
13. Mourits MP, Koomneef L, Wiersinga WM, et al. Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Br J Ophthalmol. 1989;73:639-644.
14. Wemer SC. Modification of the classification of the eye changes of Graves' disease. Am J Ophthalmol. 1977;83:725-727.
15. Haase A, Frahm J, Hanicke W, et al. 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol. 1985;30:341-344.
16. Szucs-Farkas Z, Toth J, Balazs E, et al. Using morphologic parameters of extraocular muscles for diagnosis and follow-up of Graves' ophthalmopathy: diameters, areas, or volumes? AJR Am J Roentgenol. 2002;179:1005-1010.
17. Yoshikawa K, Higashide T, Nakase Y. Role of rectus muscle enlargement in clinical profile of dysthyroid ophthalmopathy. Jpn J Neuroradiol. 1991;35:175-181.
18. Nishikawa M, Yoshimura M, Toyoda N, et al. Correlation of orbital muscle changes evaluated by magnetic resonance imaging and thyroid-stimulating antibody in patients with Graves' ophthalmopathy. Acta Endocrinol. 1993;129:213-219.
19. Polito E, Leccisotti A. MRI in Graves orbitopathy: recognition of enlarged muscles and prediction of steroid response. Ophthalmologica. 1995;209:182-186.
20. Hosten N, Sander B, Cordes M, et al. Graves' ophthalmopathy: MR imaging of the orbits. Radiology. 1989;172:759-762.
21. Hosten N, Schorner W, Lietz A, et al. The course of the disease in endocrine orbitopathy. Magnetic resonance tomographic documentation. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr. 1992;157:210-214.
22. Muller-Forell W, Pitz S, Mann W, et al. Neuroradiological diagnosis of thyroid-associated orbitopathy. Exp Clin Endocrinol Diabetes. 1999; 107: 177-183.
23. Nishida Y, Tian S, Isberg B, et al. MRI measurements of orbital tissues in dysthyroid ophthalmopathy. Graefes Arch Clin Exp Ophthalmol. 2001; 239:824-831.
24. Mayer E, Herdman G, Burnett C, et al. Serial STIR magnetic resonance imaging correlates with clinical score of activity in thyroid disease. Eye. 2001;15:313-318.
25. Yokoyama N, Nagataki S, Uetani M, et al. Role of magnetic resonance imaging in the assessment of disease activity in thyroid-associated ophthalmopathy. Thyroid. 2002;12:223-227.
26. Prummel MF, Gerding MN, Zonneveld FW, et al. The usefulness of quantitative orbital magnetic resonance imaging in Graves' ophthalmopathy. Clin Endocrinol. 2001;54:205-209.
27. Utech CI, Khatibnia U, Winter PF, et al. MR T2 relaxation time for the assessment of retrobulbar inflammation in Graves' ophthalmopathy. Thyroid. 1995;5:185-193.
28. Ohnishi T, Noguchi S, Murakami N, et al. Extraocular muscles in Graves ophthalmopathy: usefulness of T2 relaxation time measurements. Radiology. 1994;190:857-862.
29. Woodlief NF. Initial observations on the ocular microcirculation in man. I. The anterior segment and extraocular muscles. Arch Ophthalmol. 1980; 98:1268-1272.
30. Porter JD, Baker RS, Ragusa RJ, et al. Extraocular muscles: basic and clinical aspects of structure and function. Surv Ophthalmol 1995;39:451-484.
31. Weber AL, Romo LV, Sabates NR. Pseudotumor of the orbit. Clinical, pathologic, and radiologic evaluation. Radiol Clin North Am. 1999;37: 151-168.